Laboratoire d'Enzymologie et Biochimie Structurales, Centre de Recherche de Gif, CNRS, 1 Avenue de la Terrasse, 91198 Gif-sur-Yvette, France.
J Biol Chem. 2012 Oct 5;287(41):34533-46. doi: 10.1074/jbc.M112.380378. Epub 2012 Jul 31.
The amino-terminal cysteine of glucosamine-6-phosphate synthase (GlmS) acts as a nucleophile to release and transfer ammonia from glutamine to fructose 6-phosphate through a channel. The crystal structure of the C1A mutant of Escherichia coli GlmS, solved at 2.5 Å resolution, is organized as a hexamer, where the glutaminase domains adopt an inactive conformation. Although the wild-type enzyme is active as a dimer, size exclusion chromatography, dynamic and quasi-elastic light scattering, native polyacrylamide gel electrophoresis, and ultracentrifugation data show that the dimer is in equilibrium with a hexameric state, in vitro and in cellulo. The previously determined structures of the wild-type enzyme, alone or in complex with glucosamine 6-phosphate, are also consistent with a hexameric assembly that is catalytically inactive because the ammonia channel is not formed. The shift of the equilibrium toward the hexameric form in the presence of cyclic glucosamine 6-phosphate, together with the decrease of the specific activity with increasing enzyme concentration, strongly supports product inhibition through hexamer stabilization. Altogether, our data allow us to propose a morpheein model, in which the active dimer can rearrange into a transiently stable form, which has the propensity to form an inactive hexamer. This would account for a physiologically relevant allosteric regulation of E. coli GlmS. Finally, in addition to cyclic glucose 6-phosphate bound at the active site, the hexameric organization of E. coli GlmS enables the binding of another linear sugar molecule. Targeting this sugar-binding site to stabilize the inactive hexameric state is therefore suggested for the development of specific antibacterial inhibitors.
葡萄糖胺-6-磷酸合酶(GlmS)的氨基末端半胱氨酸作为亲核试剂,通过通道将氨从谷氨酰胺释放并转移到果糖 6-磷酸上。已解析出 2.5Å分辨率的大肠杆菌 GlmS 的 C1A 突变体的晶体结构组织为六聚体,其中谷氨酰胺酶结构域呈无活性构象。尽管野生型酶作为二聚体具有活性,但大小排阻色谱、动态和准弹性光散射、天然聚丙烯酰胺凝胶电泳和超速离心数据表明,二聚体与六聚体状态处于平衡状态,无论是在体外还是在细胞内。以前单独或与葡萄糖胺 6-磷酸复合的野生型酶的结构也与六聚体组装一致,由于氨通道未形成,该组装是无催化活性的。在环状葡萄糖胺 6-磷酸存在下平衡向六聚体形式的转移,以及随着酶浓度的增加比活性降低,强烈支持通过六聚体稳定进行产物抑制。总的来说,我们的数据使我们能够提出一个 morpheein 模型,其中活性二聚体可以重新排列成一种短暂稳定的形式,该形式倾向于形成无活性的六聚体。这将解释大肠杆菌 GlmS 的生理相关变构调节。最后,除了结合在活性位点的环状葡萄糖 6-磷酸外,大肠杆菌 GlmS 的六聚体组织还能够结合另一个线性糖分子。因此,建议针对该糖结合位点进行靶向,以稳定无活性的六聚体状态,从而开发出特异性的抗菌抑制剂。